Chapter

What the Report Means for Immunotherapy

From Cancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute by Samik Upadhaya, PhD

Concepts

1. Immunotherapy Reach

   "The survival gains documented in this report validate decades of investment in cancer immunology. But they also underscore how much work remains:\n\nExpand immunotherapy to more cancer types: While m

2. Early Detection

   "Close the early detection gap: Cancer stage at diagnosis remains critical – only 17% of pancreatic cancers and 28% of lung cancers are caught at the localized stage. Despite lung cancer screening red

3. Pediatric Cancers

   "Accelerate research for pediatric cancers: While five-year survival rates for some childhood cancers have improved dramatically (for example, leukemia has improved from 50% in the mid 1970s to 89% in

4. Research Funding

   "Protect research funding: The report warns that continued progress is threatened by proposed federal cuts to cancer research and health insurance. Advances in immunotherapy are the result of decades